Welcome to Genmab

Engineering a
transformative tomorrow

As a leading international biotechnology company, we believe in the transformative power of science and technology. Science is not only our bedrock, it is our inspiration. We believe in improving the lives of patients with cancer by creating and developing innovative and differentiated antibody therapeutics that will transform the future of cancer treatment. We are Genmab.

Learn more

Pipeline

Transforming the future of cancer treatment

Cancer presents constant challenges in our society—from advancing drug development to fulfilling the unmet medical needs of patients. At Genmab, we have an appreciation for the power of the human immune system that gives us a unique perspective on how to respond and find solutions. That’s why we are focused on harnessing the immune system’s natural ability to fight against diseases to create therapeutics that have the potential to transform how cancer is treated.

See our products

Our Technology Platforms

Pioneering the next generation of antibody platforms

With an in-depth knowledge of antibody biology, we discover, develop and select the best possible antibody products. This relentless drive to innovate and advance the process of antibody discovery has led to our proprietary antibody technologies.

See our science at work

LATEST NEWS

Genmab and Seagen submit tisotumab vedotin Biologics License Application to the U.S. FDA for patients with recurrent or metastatic cervical cancer

 The submission is based on the results of the innovaTV 204 pivotal phase 2 single-arm clinical trial evaluating tisotumab vedotin as monotherapy. The topline results from the phase 2 study were announced in June 2020 and data were presented at the European Society for Medical Oncology (ESMO) Virtual Congress 2020. 

Learn more

We turn science into medicine. We use our deep antibody expertise to create cancer therapeutics with the potential to improve patients’ lives.

Load more

Publication of the Annual Report for 2020

On February 23, Genmab announced its full year 2020 financial results.


View Report | Download Presentation | Danish 2020 Resume | Watch On-Demand Webcast
Join our mission to transform the future of cancer treatment.

Learn about career opportunities

You are now leaving Genmab.com to go to our collaborator’s website. If you continue, we encourage you to read the website’s privacy and cookie policy.